Literature DB >> 19123736

Flow cytometric immunophenotyping of anaplastic large cell lymphoma.

Tariq Muzzafar1, Eric X Wei, Pei Lin, L Jeffrey Medeiros, Jeffrey L Jorgensen.   

Abstract

CONTEXT: Anaplastic large cell lymphoma (ALCL) is usually diagnosed by histologic and immunohistochemical analysis. However, fine-needle aspiration is becoming a popular alternative to lymph node biopsy, and flow-cytometric immunophenotyping is often used to analyze fine-needle aspiration specimens.
OBJECTIVE: To review our experience using flow-cytometric immunophenotyping to assess cases of ALCL and to evaluate the diagnostic utility of this technique.
DESIGN: Each case of ALCL was assessed by flow cytometry with 3-color or 4-color antibody panels, and data were reanalyzed by cluster analysis using Paint-a-Gate for cases with retrievable flow cytometry data files. Anaplastic lymphoma kinase (ALK) was assessed by using immunohistochemistry.
RESULTS: Twenty-three ALCL cases were analyzed by flow cytometry. In 4 cases, neoplastic cells could not be identified. In the remaining 19 cases (11 ALK(+), 8 ALK(-)), all were positive for CD30 and CD45. Anaplastic large cell lymphoma cells were large and usually CD45 bright, with many or most cells falling in the region of monocytes on the CD45/side scatter plot. The frequencies of T-cell antigen expression in ALK(+) cases were CD2, 67%; CD7, 60%; CD3, 45%; CD4, 33%; CD5, 14%; and CD8, 14%. In ALK(-) cases, the frequencies of the T-cell antigen expression were CD2, 100%; CD3, 50%; CD4, 40%; CD7, 40%; CD5, 25%; and CD8, 20%.
CONCLUSIONS: Flow cytometry can be used to immunophenotype ALCL cases. Neoplastic cells may be few, and they may fall outside of the lymphocyte gate. Cluster analysis using software like Paint-A-Gate is often helpful because it allows for flexible, sequential gating strategies to identify and characterize the neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19123736     DOI: 10.5858/133.1.49

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

Review 1.  Peripheral T and NK cell non-hodgkin lymphoma a challenge for diagnosis.

Authors:  Daniela Vasile; Ana-Maria Vladareanu; Horia Bumbea
Journal:  Maedica (Buchar)       Date:  2014-03

2.  Expression of CD8 is associated with non-common type morphology and outcome in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Authors:  Dmitriy Abramov; Ilske Oschlies; Martin Zimmermann; Dmitriy Konovalov; Christine Damm-Welk; Wilhelm Wössmann; Wolfram Klapper
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

3.  Flow cytometric immunophenotyping and cell block immunocytochemistry in the diagnosis of primary Non-Hodgkin's Lymphoma by fine-needle aspiration: Experience from a tertiary care center.

Authors:  Tuhin Paul; Upasana Gautam; Arvind Rajwanshi; Ashim Das; Amita Trehan; Pankaj Malhotra; Radhika Srinivasan
Journal:  J Cytol       Date:  2014-07       Impact factor: 1.000

4.  Immunophenotypic shifts during minimal residual evaluation in a case of leukemic form of anaplastic large cell lymphoma ALK.

Authors:  Maria Clara Canellas; Enrico Bruno-Riscarolli; Cristiane S Ferreira-Facio; Daiana V Lopes-Alves; Vitor D Botafogo; Deborah Sutter; Roberia M Pontes; Marcelo G P Land; Cristiane Bedran Milito; Elaine Sobral da Costa
Journal:  Cancer Rep (Hoboken)       Date:  2021-08-11

5.  Simultaneous cytomorphological and multiparameter flow cytometric analysis of ALK-positive anaplastic large cell lymphoma in children.

Authors:  Hongqiang Shen; Yongmin Tang; Xiaojun Xu; Hongfeng Tang; Weizhong Gu
Journal:  Oncol Lett       Date:  2012-11-19       Impact factor: 2.967

6.  Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.

Authors:  Cristiane S Ferreira-Facio; Cristiane Milito; Vitor Botafogo; Marcela Fontana; Leandro S Thiago; Elen Oliveira; Ariovaldo S da Rocha-Filho; Fernando Werneck; Danielle N Forny; Samuel Dekermacher; Ana Paula de Azambuja; Sima Esther Ferman; Paulo Antônio Silvestre de Faria; Marcelo G P Land; Alberto Orfao; Elaine S Costa
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

7.  Recombinant expression, characterization, and quantification in human cancer cell lines of the Anaplastic Large-Cell Lymphoma-characteristic NPM-ALK fusion protein.

Authors:  Katerina Kourentzi; Mary Crum; Ujwal Patil; Ana Prebisch; Dimple Chavan; Binh Vu; Zihua Zeng; Dmitri Litvinov; Youli Zu; Richard C Willson
Journal:  Sci Rep       Date:  2020-03-19       Impact factor: 4.379

8.  The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis.

Authors:  Lianqun Qiu; L Jeffrey Medeiros; Guilin Tang; Mahsa Khanlari; Shaoying Li; Sergej Konoplev; Sa A Wang; C Cameron Yin; Joseph D Khoury; Wei Wang; Roberto N Miranda; Swaminathan Iyer; M James You; Jie Xu
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.